HopeStage
Back to all studies
RecruitingNCT07279558

Full-spectrum CBD and drinking patterns in people who drink regularly

About this title

Cannabidiol and Alcohol Use Disorder Phenotypes

Read the official source — NCT07279558
Medication studyAges 21–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

What will I do during this study?

You are assigned to full-spectrum CBD, broad-spectrum CBD or placebo (an inactive comparison treatment), taken daily for eight weeks. The study describes up to five in-person visits over about 13 weeks, daily surveys and weekly online check-ins. One visit is an experimental lab session where alcohol is offered.

Listed locations
AuroraSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Number of visits
Up to 5 in-person visits over about 13 weeks, plus weekly virtual check-ins.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 21, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
150
Sponsor
University of Colorado, Denver
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT07279558
Official title
Show the full official title

Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine

Recruitment & locations

Currently recruiting

Aurora

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Colorado, Denver, a university.

Does this study involve medication?

Yes. The study involves medication, including Full-Spectrum Cannabidiol (CBD), Broad-Spectrum Cannabidiol (CBD) and Placebo.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies